chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt started experiencing localized redness and itching around the injection site.  It was about 2inches around described by the patient. This symptom started about a week after receiving the vaccine.
12/20/21 I had pneumonia and was being treated for that at home had not left the house. I was starting to feel better but still with a cough, I was exposed through my family members on Jan 3rd. Jan 7th I wasn't feeling well and took a Covid home test and it was positive. I got a pcr test done at pharmacy and notified Jan 10th that it was positive. Jan 17th I got the antibody treatment. I was told to wait 4 months before getting the booster with covid I started having different breathing problems from when I had pneumonia, which was shortness of breath and had to nebulizer.
Administered Moderna Bivalent Dark pink cap (yellow label) after being notified that monovalent covid vaccines were no longer authorized. Was administered prior to recommendation of using dark blue Moderna bivalent cap (gray label)
INJECTION SITE PAIN (ARM SORE AND ACHY); This spontaneous report received from a consumer concerned an adult male. The patient's height, and weight were not reported. The patient's concurrent conditions included moderate to severe polyarticular juvenile idiopathic arthritis, and moderate to severe rheumatoid arthritis. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. Non-company suspect drugs included: adalimumab (solution for injection in pre-filled syringe, subcutaneous, batch number was not reported) dose, frequency, and therapy dates were not reported for moderate to severe polyarticular juvenile idiopathic arthritis, and moderate to severe rheumatoid arthritis. The batch number was not reported, per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the subject experienced injection site pain (arm sore and Achy). The action taken with covid-19 vaccine ad26.cov2.s, and adalimumab was not applicable. The patient was recovering from injection site pain (arm sore and Achy). This report was non-serious.
Left upper arm, deltoid area; red, swollen and painful. Began on 9/20/00. Seen in MD office on 9/21/00 at 10:15. Left upper arm, red, swollen, warm to touch and painful area of redness 3 3/4" by 3". Injection site of IPV, not involved.
This spontaneous report was received from a pharmacist, via a company representative, and refers to a currently 81 year old male patient with heparin allergy. Concomitant therapies included metoprolol, nitroglycerin (manufacturer unknown), terazosin, furosemide (manufacturer unknown), atorvastatin, potassium (unspecified), fish oil, Vitamin B12, Vitamin D3, aspirin (manufacturer unknown). The patient's medical history was not reported. On 01-SEP-2017, the patient was vaccinated with a dose of ZOSTAVAX for immunization (strength, dose, route, frequency, lot/batch # and expiration date were not reported). Other suspects therapies included sterile diluent (manufacturer unknown) (strength, dose, route, frequency, indication, lot/batch # and expiration date were not reported). It was reported that the patient did have preexisting condition of lymphocytosis and normally had higher white blood cell count, however, after ZOSTAVAX vaccination, on an unknown date in 2017, the patient experienced increase in white blood cell count, it went up even higher from "39 to 51" (unknown units, "routine blood work"). The patient did not received treatment for the event, did not need intervention to prevent serious criteria, did not presented disability or incapacity, did not need hospitalization and the event was not life threatening event. The outcome of white blood cell count increased was unknown. The causality between white blood cell count increased with ZOSTAVAX and sterile diluent (manufacturer unknown) was not reported.
The nurse vaccinator reported that the patient did not receive a full dose of the vaccine due to a scant amount of the vaccine leaking from the Luer Lock connection.
On 06/01/2021, 03:00 AM extreme dizziness. It went away within 1/2 hour. 06/01/2021, that same morning, I went to the doctor's office and the extreme dizziness  happened again. They sent me in an ambulance to the hospital. They eliminated a stroke with a lot of test. I stayed overnight at the hospital. I did exercise, vision, and vestibular balance practice. Once I got to the hospital it was continuous since then. I came home for the next 2 weeks I had PT, head movements to try to lessen the problem. I have recovered 95%, there is still a little of an effect from it.
This spontaneous report as received from an office manager refers to an unspecified number of patients of unknown age and gender. No information regarding the patients' medical history or concurrent conditions was provided. On unknown dates, the patients were subcutaneously vaccinated with improperly stored doses of VARIVAX injection (lot# M023380, expiry date 11-MAY-2018; exact dose was not reported), reconstituted with properly stored doses of sterile diluent (DILUENT MRK). The doses of the vaccine were exposed to a temperature excursion of -9 to 8 degrees Celsius (also reported as 6 degrees Celsius) on an unknown date, for a time frame of 1252 hours. There were no previous temperature excursions. A Digital Data Logger was involved. No side effects were reported. There was no product quality complaint involved. Additional information has been requested.
Red rash above right eye: small bumps; itchy, painful. M.D. prescribed MethylPREDNISolone, 4 mg tablets
Information has been received from a physician concerning a 13-month old female who on 25-Nov-2003 was vaccinated with a 0.5 ml first dose of varicella virus vaccine live (lot #646239/0592N). There as no concomitant medication. On 16-Dec-2003 the patient developed chickenpox. It was noted that prescription drug treatment was not required. Subsequently, the patient recovered from chickenpox. No further information is expected.
This case was reported by a physician via call center representative and described the occurrence of injection site pain in a 59-year-old male patient who received SHINGRIX (batch number 32PE4, expiry date 23rd January 2021) for prophylaxis. Concomitant products included SHINGRIX. On 24th July 2018, the patient received the 2nd dose of SHINGRIX (intramuscular) .5 ml. On 25th July 2018, 1 days after receiving SHINGRIX, the patient experienced injection site pain, fever, myalgia and headache. The patient was treated with TYLENOL. On an unknown date, the outcome of the injection site pain, fever and headache were recovered/resolved and the outcome of the myalgia was recovering/resolving. It was unknown if the reporter considered the injection site pain, fever, myalgia and headache to be related to SHINGRIX. Additional details were reported as follows: The patient was a eye doctor. The patient reported that he experienced fever, which went as high as 99.8 Degree F. The patient was taking TYLENOL to control fever. This case was link with case US2018082757, reported for the same reporter for the same patient.
headache; This is a spontaneous report from a Pfizer-sponsored program from a contactable consumer (patient). A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration on 11Feb2021 (Batch/Lot number was not reported) as dose 1, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced headache on Feb2021 with outcome of unknown. Patient was asking if he can take Tylenol because he experienced a headache.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
pain; barely had sleep; restless last night; left arm is swollen; I feel irritated; body ache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (pain), INSOMNIA (barely had sleep), RESTLESSNESS (restless last night), PERIPHERAL SWELLING (left arm is swollen) and IRRITABILITY (I feel irritated) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Cardiac valve prosthesis user (artificial valve for the heart). Concomitant products included METOPROLOL for Heart disorder.   On 13-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-May-2021, the patient experienced PAIN (pain), INSOMNIA (barely had sleep), RESTLESSNESS (restless last night), PERIPHERAL SWELLING (left arm is swollen), IRRITABILITY (I feel irritated) and MYALGIA (body ache). The patient was treated with IBUPROFEN for Adverse event, at a dose of 1 dosage form and TRAMADOL for Adverse event, at an unspecified dose and frequency. At the time of the report, PAIN (pain), INSOMNIA (barely had sleep), RESTLESSNESS (restless last night), PERIPHERAL SWELLING (left arm is swollen), IRRITABILITY (I feel irritated) and MYALGIA (body ache) had not resolved.            Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 22-Jul-2021: NNI
Hives on upper body - particularly shoulders, chest, back.  Severe itching. Prescribed Zyirtce / cetirizine 10 mg in morning; Pepcid or famotidine 20 mg twice daily; Benadryl or diphenhydramine 25 mg nightly (am still taking prescription - one month after injection - as slight symptoms still exist.
Shot given immediately following nasal flu vaccine, to left arm. He immediately felt faint, had whole body severe pains and severe headache, stomach cramps and nausea. He was assisted to a chair then a table to lie down.
(L) arm injection site warm to touch/tender headache, nausea, ache, pain, diarrhea. Supraclavicular lymph node enlargement.
Pain all over the body after Second Shot; Tired after Second Shot; Fever after Second Shot; Felt like a truck ran them over after Second Shot; Headache after Second Shot; This spontaneous case was reported by a consumer and describes the occurrence of SENSATION OF FOREIGN BODY (Felt like a truck ran them over after Second Shot), HEADACHE (Headache after Second Shot), MYALGIA (Pain all over the body after Second Shot), FATIGUE (Tired after Second Shot) and PYREXIA (Fever after Second Shot) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, the patient experienced SENSATION OF FOREIGN BODY (Felt like a truck ran them over after Second Shot) and HEADACHE (Headache after Second Shot). On an unknown date, the patient experienced MYALGIA (Pain all over the body after Second Shot), FATIGUE (Tired after Second Shot) and PYREXIA (Fever after Second Shot). In February 2021, SENSATION OF FOREIGN BODY (Felt like a truck ran them over after Second Shot) had resolved. In March 2021, HEADACHE (Headache after Second Shot) had resolved. At the time of the report, MYALGIA (Pain all over the body after Second Shot), FATIGUE (Tired after Second Shot) and PYREXIA (Fever after Second Shot) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant Product reported by the reported  No treatment reported by the reporter   This case was linked to MOD21-065752, MOD21-065780 (E2B Linked Report).; Sender's Comments:  MOD21-065752:Case for husband (Patient) MOD21-065780:case for wife
Patient tested positive for Covid 19 on 12/06/21 at long term care facility where she currently resides. She received  MAB infusion on 12/07/21. She presented on 12/9 to the ED  patient was initially hypoxic to 89% on room air which improved on 3L NC. Patient was normotensive and afebrile. CRP was 0.95. D-dimer was 1993.   Chest x-ray revealed a right lower lobe infiltration consistent with pneumonia. EKG was nonischemic. Patient was given one dose of Rocephin and azithromycin in the emergency department for community-acquired pneumonia. Patient was admitted for acute hypoxemic respiratory failure secondary to COVID pneumonia with possible concurrent CAP.  Pt was started on Remedesvir, decadron, vitamin C, D, and zinc, Albuterol PRN, guafenesin PRN for COVID-19 pneumonia. She was not started on antibiotics since her procalcitonin was not elevated enough to suggest a bacterial pneumonia. On 12/10-12/11 pt was on 5-6 L NC throughout day, desaturations with activity, mild subjective dyspnea. On 12/13 patient continued to have oxygen requirements around 3L and she was stable to discharge back to her SNF with home healthcare.
1st dose vaccine 1/23/21; 2nd dose vaccine 2/13/21; developed sore throat, night sweats, chest tightness 2/21/21; seen at ICC for ongoing symptoms on 2/25/21
Pt was given vaccine, 5 min after pt became dizzy and face became pale, pt passed out for a few second, 911 was called pt declined EMT attention, pt states he was fine after resting for 10 min.
was not ill prior to vaccine. 3 days later started getting rash on neck. went to doctor was told it was shingles. never had any warning signs of shingles. I had just had a complete health check a couple months prior and everything was OK.
The following day after my booster I started this headache and just comes in waves. I suspected this would just subside but has not stopped. I went to go workout the day after my booster and started to have sharp pain over the left side of my chest. It subsides when I don?t exert myself. Every time I have tried to go back to working out I have gotten the sharp pain. I don?t have DIB it just hurts to breath.We are traveling so when I get back, I have made an apt with my doctor.
This spontaneous report as received from a healthcare worker, refers to a patient of unknown age and gender. No pertinent medical history, drug reactions/allergies or concurrent conditions were reported. On 18-APR-2016, the patient was vaccinated with 0.5 ml dose of improperly stored (Merck) VARIVAX (which had a lot # of L040419 and an expiration date of 14-OCT-2017; however, dosage number and route of administration were not reported). Nonetheless, no adverse effects were reported. Another batch of (Merck) VARIVAX (which had a lot # of L043624 and an expiration date of 03-NOV-2017) had also been improperly stored but it was not reported whether it had been administered. The vaccines experienced the following temperature excursions on the following dates: 10 F for 2 hours and 15 minutes on 24-MAR-2016; 12.4 F for 2 hours and 15 minutes on 26-MAR-2016; 10.4 F for 2 hours and 15 minutes on 30-MAR-2016; 10 F for 2 hours on 03-APR-2016; and 9.3 F for 1 hour and 45 minutes on 07-APR-2016. . Reportedly, there had been no previous temperature excursions and the aforementioned ones were identified due to a data logger. Furthermore, no product quality complaint was involved. This is one of the several reports received from the same reporter. Additional information has been requested.
Nausea/ Diaphoresis Nausea Ended 11:05Am Diaphoresis Ended 11:15Am observed 30min. Resolved.
This spontaneous report was received from a registered nurse and refers to multiple patients of unknown age and gender. Information regarding pertinent medical history, drug reactions or allergies and concomitant therapies were not provided. On 31-AUG-2017, the patients were vaccinated with improperly stored doses of PROQUAD (lot # N010114 with expiry date 24-SEP-2018 and lot # N012489 with expiry date 17-OCT-2018) (dose, route and frequency were not reported) reconstituted with properly stored sterile diluent (MRK INJ) for prophylaxis. No adverse effects reported. The administered doses experienced a temperature excursion of -9 degree Celsius to 8 degree Celsius for a time frame of 2 hours. There was no previous temperature excursions and data logger was not involved. There was no Product Quality Complaint (PQC) involved.
General malaise, muscle aches, fatigue and headaches/ Brain fog. The headaches and brain fog have lasted until current day(8/9/21) .
Mother of child thinks she had HepB series 2 yrs ago, but could not find records. This may have been the 6th vax given. Left arm, itchy first night, then erythema and swelling the next day (localized).No systemic reaction.
sick; Rash at injection site; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (sick) and INJECTION SITE RASH (Rash at injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (sick) and INJECTION SITE RASH (Rash at injection site). At the time of the report, ILLNESS (sick) and INJECTION SITE RASH (Rash at injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medication was reported. Treatment information was not provided.   Reporter did not allow further contact
Strong dizziness/vertigo starting at about 3am when I woke up. Lasting till now, 11:15am. Duration at present: 8 hours.
Sweating; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (Sweating) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013m20a and 038k20a) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HYPERHIDROSIS (Sweating). At the time of the report, HYPERHIDROSIS (Sweating) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not reported. Treatment information in response to events was not provided.
pt recvd vax;T 99.2;dec appetite;inc somnolence;fussiness;rule out sepsis; nystatin given for perineal rash;CSF & blood culture neg;mild rash behind both ears;thought to be due to ampicillin;
A report has been received from a Health Professional concerning a 1 year old, Female patient, who had been receiving FLUMIST quadrivalent (intranasal). FLUMIST quadrivalent (intranasal) started on an unknown date. The nurse reported that they inadvertently administered FLUMIST quadrivalent which started on 04-Oct-2013. The outcome of the event of we inadvertently administered FLUMIST quadrivalent is unknown. The report was considered to be non-serious.
Patient is fully vaccinated. Diagnosed with Covid on Saturday (11/27/2021) was being evaluated for monoclonal antibody treatment and she told them she had bilateral upper back pain and some mild chest tightness and they told her to go to the ER to be evaluated prior to them clearing her for the therapy.  She has a pulse ox at home and has never dropped below 94%.BP 128/69  | Pulse 68  | Temp 98.2 °F (36.8 °C) (Oral)  | Resp 18  | SpO2 100% Medications: ketorolac (TORADOL) injection 15 mg and potassium chloride. Pt stable and discharged.
Right upper arm intense pain .  45 minutes later I laid down in bed and it was like explosions in my upper body, torso and arms.  Intense pow-pow, - pow pow pow on and on for an hour  Intense in my left arm but continued constantly for about an hour.  When it subsided I got  intense chills radiating up and down  my legs,.  That stopped and I had  regular chills throughout my body.  Started to have a headache.  Went to sleep after some time, and when I awoke the next morning, I had such fatigue, I could hardly get out of bed.   I spent the next two days sleeping most of the day.  I did not eat because I just wanted to sleep.
Five days after the injection, a rash started on my right forearm. Within 48 hours of onset, the rash had spread to all four limbs. By day three post onset, the rash covered all of my body, excluding face, hands, and feet. By day eight, the rash began weeping on my right forearm, similar to sun poison, or poison ivy. It is currently day 12 and my rash is dry and scabby on my right forearm, thighs, and knees.   On day three of this reaction, I went to the place a received the vaccine to show the nursing staff. They said the rash looked ?lacy like Hand, Foot, Mouth Disease? and suggested I go to the immediate care to get evaluated. The physician?s assistant said it was a reaction to the vaccine. She suggested taking over the counter allergy medications. I have been taking Benadryl consistently and applying cortisone 10 and calamine on areas where it itches most
About 1/2 hour after shot all of sudden had weird feeling and shortly  after felt nauseated.  Kept shopping in store for awhile and arrived home between 4 and 4;30.   Took temp which was 96.6.  Sometime after developed a very sore throat and occasional deep cough.  Went to bed about 11;30 and my throat was fine.  Took temp was 94.4.  Felt ok in morning
Feels like the side of shoulder was scraped. Pains shooting down to the elbow,  every time he moves.  If he touches the skin where the shot was given the bone hurts at that location.
started 21NOV til 25NOV w/watery diarrhea, headache, ache all over, queasy stomach, general malaise;
Fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever). At the time of the report, PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication were used. No treatment medication were used.
Immediately after vaccine I started feeling pain, it got so bad I went into ER. I was diagnosed with cellulitis from the vaccine. I was no longer able to stay awake. I constantly fell asleep, nothing could keep me awake. I was then diagnosed with adrenal fatigue and Hashimotos disease.
It caused me to start having seizures for 3 days.  I checked with my neurologist if this was a possibility seeing I hadn't had them for a while and was doing well. They said yes.  It lowered the threshold of my meds and caused my seizures.
Complaining of soreness, noted swelling to site. Given Motrin, no complaint until the evening of 2/4/2010, increased soreness, swelling, red hot approx 12cm area
Site of injection reddened, hot to touch, raised, swollen, 3 inches in diameter.